Key facts
- Sushain’s last known valuation is $1.6M (Apr 2024).
- It has raised $220K; the latest was Angel (individual) in Aug 2025.
- Notable investors include Ajeya Singh, DTU Innovation and Incubation Foundation, Prajay Advisors.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Sushain
- ·The full record, as it builds
Funding rounds
No funding rounds for Sushain are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sushain
Developer of a digital health platform designed to provide telepharmacy and ayurvedic treatment. The company makes traditional medicine practices accessible and reliable worldwide and also provides services from virtual consultations to Panchkarma therapy, along with a wide selection of Ayurvedic and Homeopathic products, enabling people to connect with Ayurvedic doctors for video consultations and order medicines online.
- Sector
- Healthcare
- HQ
- Lucknow, India
- Founded
- 2021
- Employees
- 29
- Website
- sushainclinic.com/
- Ownership
- Privately Held (backing)
Sushain doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sushain shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sushain in its N-PORT filings yet. We sweep new filings monthly.